Literature DB >> 6292905

Cloning and characterization of different human sequences related to the onc gene (v-myc) of avian myelocytomatosis virus (MC29).

R Dalla-Favera, E P Gelmann, S Martinotti, G Franchini, T S Papas, R C Gallo, F Wong-Staal.   

Abstract

We have studied the genomic organization of human cellular sequences (c-myc) homologous to the transforming gene (v-myc) of avian myelocytomatosis virus (MC29). Southern blotting experiments using v-myc probes showed that several fragments of the human genome contain sequences related to the central part of v-myc but only few of them are homologous to the 3' portion of the viral gene. Several recombinant phages which represent different regions of the genome containing c-myc-related sequences were isolated from a human DNA library. Two clones (lambda-LMC-12 and -41) overlap over approximately 17 kilobases of DNA where a sequence homologous to that of the entire v-myc is present. Restriction mapping experiments and heteroduplex analysis show that c-myc sequences of this locus are interrupted by one intron, suggesting that lambda-LMC-12 and -41 contain the complete functional c-myc gene. Three other clones (lambda-LMC-3, -4, and -26) do not overlap and contain sequences related to only approximately 0.3 kilobase of v-myc but lack 5' and 3' portions of the gene. These sequences are not interrupted by introns and are more divergent from v-myc than is the complete gene, suggesting that they may represent either pseudogenes or parts of distantly related genes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6292905      PMCID: PMC347154          DOI: 10.1073/pnas.79.21.6497

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene.

Authors:  M Grunstein; D S Hogness
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

Review 2.  Avian leukemia viruses: interaction with their target cells in vivo and in vitro.

Authors:  T Graf; H Beug
Journal:  Biochim Biophys Acta       Date:  1978-11-17

3.  Identification of nucleotide sequences which may encode the oncogenic capacity of avian retrovirus MC29.

Authors:  D Sheiness; L Fanshier; J M Bishop
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

4.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

5.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

6.  Two types of target cells for transformation with avian myelocytomatosis virus.

Authors:  T Graf
Journal:  Virology       Date:  1973-08       Impact factor: 3.616

7.  The isolation of structural genes from libraries of eucaryotic DNA.

Authors:  T Maniatis; R C Hardison; E Lacy; J Lauer; C O'Connell; D Quon; G K Sim; A Efstratiadis
Journal:  Cell       Date:  1978-10       Impact factor: 41.582

8.  Avian acute leukemia viruses MC29 and MH2 share specific RNA sequences: evidence for a second class of transforming genes.

Authors:  P H Duesberg; P K Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

9.  Construction and characterization of new cloning vehicles. II. A multipurpose cloning system.

Authors:  F Bolivar; R L Rodriguez; P J Greene; M C Betlach; H L Heyneker; H W Boyer; J H Crosa; S Falkow
Journal:  Gene       Date:  1977       Impact factor: 3.688

10.  The nucleotide sequence of oocyte 5S DNA in Xenopus laevis. II. The GC-rich region.

Authors:  J R Miller; E M Cartwright; G G Brownlee; N V Fedoroff; D D Brown
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

View more
  93 in total

1.  Quantitative mRNA expression analysis from formalin-fixed, paraffin-embedded tissues using 5' nuclease quantitative reverse transcription-polymerase chain reaction.

Authors:  T E Godfrey; S H Kim; M Chavira; D W Ruff; R S Warren; J W Gray; R H Jensen
Journal:  J Mol Diagn       Date:  2000-05       Impact factor: 5.568

2.  Control of vascular smooth-muscle cell growth by macrophage-colony-stimulating factor.

Authors:  T Herembert; J Gogusev; D L Zhu; T B Drueke; P Marche
Journal:  Biochem J       Date:  1997-07-01       Impact factor: 3.857

3.  Plateau distributions of DNA fragment lengths produced by extended light exposure of extranuclear photosensitizers in human cells.

Authors:  E Kvam; T Stokke; J Moan; H B Steen
Journal:  Nucleic Acids Res       Date:  1992-12-25       Impact factor: 16.971

4.  HIT cells secrete β-cell mitogenic factors.

Authors:  B Bréant; A Lieuvin; C Lavergne; J C Marie; G Rosselin
Journal:  Endocrine       Date:  1995-01       Impact factor: 3.633

5.  Molecular genetic analysis of lymphoid tumors arising after organ transplantation.

Authors:  J Locker; M Nalesnik
Journal:  Am J Pathol       Date:  1989-12       Impact factor: 4.307

6.  Accurate and efficient transcription of human c-myc genes injected into Xenopus laevis oocytes.

Authors:  K Nishikura; S Goldflam; G A Vuocolo
Journal:  Mol Cell Biol       Date:  1985-06       Impact factor: 4.272

Review 7.  Human oncogenes.

Authors:  K Willecke; R Schäfer
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

8.  Human proto-oncogene N-myc encodes nuclear proteins that bind DNA.

Authors:  G Ramsay; L Stanton; M Schwab; J M Bishop
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

9.  A detailed analysis of chromosomal changes in heritable and non-heritable retinoblastoma.

Authors:  J Squire; B L Gallie; R A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

10.  Internucleosomal DNA fragmentation during phorbol ester-induced monocytic differentiation and G0/G1 arrest.

Authors:  H Gunji; R Hass; D Kufe
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.